Business · 19/10/2026

HistoIndex and A*STAR Partner to Advance Early-Stage Development of Pipeline Therapies for Fibrotic Diseases

HistoIndex, a leading provider of AI-driven digital pathology solutions for fibrotic diseases, has partnered with the Agency for Science, Technology and Research (A*STAR), Singapore's premier public sector research and development agency, to accelerate the development of pipeline therapies for fibrotic diseases.

Source: PR NewswireOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Business · 10/19/2026

Partnerships for prosperity - unlocking regional potential

Speech by Dr P Nandalal Weerasinghe, Governor of the Central Bank of Sri Lanka, at the 49th Annual General Meeting of the Association of Development Financing Institutions in Asia and the Pacific (ADFIAP), Colombo, 23…

Read summary →

Business · 10/19/2026

Effective supervision through timely remediation

Contribution by Mr Frank Elderson, Member of the Executive Board of the European Central Bank and Vice-Chair of the Supervisory Board of the European Central Bank, to the panel discussion “Effective supervision and en…

Read summary →

Business · 10/19/2026

Vector Science and Therapeutics Corp. Appoints Angus Jackson as Managing Director of Corporate Development

Jackson to lead organic and inorganic growth initiatives, strategic partnerships and corporate development as the Company advances its life sciences and therapeutics platforms TORONTO, Oct. 19, 2026 /PRNewswire/ -- Ve…

Read summary →

Business · 10/19/2026

DataOne Adds Massachusetts Registration and Sales Data to Cross-Sell Reports for Auto Dealers, Expanding State Coverage to 40 States

BEVERLY, Mass., Oct. 19, 2026 /PRNewswire/ -- DataOne Software, a Dominion Enterprises company and a leading provider of automotive data and software solutions, today announced the availability of Massachusetts vehicl…

Read summary →

Business · 10/19/2026

Actinium Pharmaceuticals to Showcase ATNM-400's First-in-Human Clinical Data in Prostate Cancer and Preclinical Results in Lung Cancer Supporting Pan-Tumor Potential Today at EANM 2026

First-in-human Phase 1 presentation to feature ATNM-400 clinical data in metastatic castration-resistant prostate cancer, advancing a differentiated approach beyond PSMA Preclinical presentation to feature ATNM-400 st…

Read summary →

Business · 10/19/2026

LINDBLAD EXPEDITIONS HOLDINGS, INC. TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS ON NOVEMBER 3, 2026

NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND; "Lindblad"; the "Company"), a global provider of expedition cruises and adventure travel experiences, will report 2026 third q…

Read summary →